By Tony Fong

NEW YORK (GenomeWeb News) – Coming off a soft second quarter, Greg Lucier, CEO of Life Technologies said at the UBS Global Life Sciences Conference today that the company is "now repositioning" itself for the challenges it faces ahead and has started the process of righting itself.

He also highlighted the performance of Life Tech's Ion Torrent Personal Genome Machine benchtop sequencer, saying it has seen "incredible uptake."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.